Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways-Reference-Cited by-同舟云学术

Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways

Published:2021-02-09 Issue: Volume:27 Page:
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Zhou Jingwen¹,Zhang Xiaolong¹,Wan Lingfeng¹,Yu Jun²,Li Tianci²,Lu Ziyu³,Fang Nanyuan¹,Sun Lixia¹,Ye Fang²

Affiliation:

1. Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China (mainland)

2. The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland)

3. School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway;Chinese Journal of Natural Medicines;2024-03

2. The direct binding of bioactive peptide Andersonin-W1 to TLR4 expedites the healing of diabetic skin wounds;Cellular & Molecular Biology Letters;2024-02-05

3. Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease;Chinese Journal of Natural Medicines;2023-09

4. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway;Journal of Biochemical and Molecular Toxicology;2023-05-21

5. Advances in traditional Chinese medicine for liver disease therapy in 2021;Traditional Medicine Research;2022